Skip to content

FARMAFLEX

Active
Private limited companyfounded 1987active for 39 yearsSantvoortbeeklaan 18, 2100 Antwerpen, BelgiumKBO/BCE: BE 0430.701.675
Summary

FARMAFLEX has been active since 1987 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €151,191 and a net result of €578. Equity is shrinking by about 2.9% per year across the filed financial years. Its solvency ranks better than 40% of 12,678 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow ReportCompare
FARMAFLEXActiveChecked score 88/100
Risk analysis ReportCompare

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
€549,186total assets 2025
Equity
€151,191
Profit
€578
Turnover not published (abbreviated format)
Financial health
88 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
Parent
NEW WORLD · 100%
2025 accounts 3 days early1 of 7 deeds summarised
Why 88raises riskSector: Retail trade (NACE 47)Liquidity: current ratio 9.56, cash €9,005, halvedlowers riskSize: total assets €549,186Founded in 1987Show the evidence

Checked score

Score 2025
88 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 47% of its sector peers (NACE 47, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Average
Solvency 53+1
equity 27.5% of total assets
Liquidity 52-4
short-term debt 7.9% · cash 1.6%
Profitability 69-2
return on assets 0.1%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,242 companies, NACE 47, micro)
Last 24 months 11-2024: 0.3% 12-2024: 0.3%● unchanged vs 11-2024 01-2025: 0.3%● unchanged vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.3%● unchanged vs 02-2025 04-2025: 0.3%● unchanged vs 03-2025 05-2025: 0.3%● unchanged vs 04-2025 06-2025: 0.3%● unchanged vs 05-2025 07-2025: 0.5%▲ +0.2 percentage points vs 06-2025highest value 08-2025: 0.1%▼ -0.4 percentage points vs 07-2025lowest value 09-2025: 0.1%● unchanged vs 08-2025lowest value 10-2025: 0.1%● unchanged vs 09-2025lowest value 11-2025: 0.1%● unchanged vs 10-2025lowest value 12-2025: 0.1%● unchanged vs 11-2025lowest value 01-2026: 0.1%● unchanged vs 12-2025lowest value 02-2026: 0.1%● unchanged vs 01-2026 03-2026: 0.1%● unchanged vs 02-2026 04-2026: 0.2%▲ +0.1 percentage points vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.2%● unchanged vs 06-2026 08-2026: 0.2%● unchanged vs 07-2026 09-2026: 0.2%● unchanged vs 08-2026 10-2026: 0.2%● unchanged vs 09-2026
Credit of up to €13,000 on 30-day terms is acceptable
Liquidity ample (current ratio 9.56, compared with 9.8 in 2024, above the usual 1.5; short-term debt: 7.9% and cash: 1.6% of total assets), but 72.5% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 43% on solvency, 57% on liquidity, 49% on profitability and 41% on growth.

The bankruptcy probability was computed on 25-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Size: total assets €549,186
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Founded in 1987
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Liquidity: current ratio 9.56, cash €9,005, halved
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 28-07-2026, 3 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
3 days early
2024
2 days early
2023
5 days early
2022
3 days early
2021
2 days early
2020
2 days early
2019
31 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 2 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
26-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Back to profitnet €9,811

Key points

  • Controlled by NEW WORLD 100% View
  • Positive: Filed on time since financial year 2020accounts within the deadline every year 6 years View
  • Active since 1987founded 22-03-1987 39 years View

By topic

Financials

Financial year
2025
Total assets
€549,186
Profit
€578
Solvency
27.5%
Total assets▼ 3.0%
Net result
20182025
Go to Financials

Board & ownership

Board
2 members
Parent
NEW WORLD · 100%
  • CHEUNG CarmenDirector
  • CHEUNG Wai KwongDirector
Go to Board & ownership

Timeline

Events
42
Since
1988
Next accounts
by 31-07-2027
  1. 31-12-2024Equity above €150,000
  2. 26-07-2024Annual accounts filed
  3. 20-09-2023Resignations: CHEUNG Wai Kwong (director) and CHEUNG…
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
22-03-1987
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Key facts about FARMAFLEX

What is the company number of FARMAFLEX?
0430.701.675. In Belgium the VAT number is the company number with BE in front: BE 0430.701.675.
Where is FARMAFLEX based?
The registered office is at Santvoortbeeklaan 18, 2100 Antwerpen.Company details
What does FARMAFLEX do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of FARMAFLEX?
Private limited company (BV).
When was FARMAFLEX founded?
On 22-03-1987.
Is FARMAFLEX still active?
Yes, FARMAFLEX is an active enterprise in the KBO register.
What is the turnover of FARMAFLEX?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is FARMAFLEX profitable?
In financial year 2025, FARMAFLEX made a profit of €578.
Where can I find the annual accounts of FARMAFLEX?
FARMAFLEX filed 38 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of FARMAFLEX due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to FARMAFLEX

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure